Characteristics of (3H)E-643-binding to alpha adrenoceptors.
Fumiaki Hata, Etsuo Kondo, Shigeru Kondo, Kimiya Kagawa, Hajime Ishida
Abstract
Fumiaki Hata, Etsuo Kondo, Shigeru Kondo, Kimiya Kagawa, Hajime Ishida
Abstract
Radiolabeled E-643, a newly developed antihypertensive compound, bound specifically to a preparation obtained from rat brain with a maximum of 85 f moles of binding sites per mg protein and a dissociation constant of 0.59 nM. Prazosin markedly inhibited the binding. While yohimbine and clonidine were only weak inhibitors. Other characteristics of the binding of [3H]E-643 to the brain and its specific binding to preparations of peripheral rat organs were also studied. The present findings suggest that [3H]E-643 is useful for labeling alpha 1-adrenoceptors.
OpenAlex reports 36 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Radiolabeled E-643, a newly developed antihypertensive compound, bound specifically to a preparation obtained from rat brain with a maximum of 85 f moles of binding sites per mg protein and a dissociation constant of 0.59 nM. Prazosin markedly inhibited the binding. While yohimbine and clonidine were only weak inhibitors. Other characteristics of the binding of [3H]E-643 to the brain and its specific binding to preparations of peripheral rat organs were also studied. The present findings suggest that [3H]E-643 is useful for labeling alpha 1-adrenoceptors.
Key concepts: Alpha (finance), Adrenergic receptor, Internal medicine, Medicine, Mathematics, Receptor, Statistics, Construct validity